GA2-Ganglioside, Asialoganglioside-GM2;Gangliotriosylceramide;GgOse3Cer

GA2-Ganglioside , Asialoganglioside-GM2; Gangliotriosyl ceramide; GgOse3Cer; b-GalNAc-(1?4)-b-Gal-(1?4)-b-Glc-(1?1')-Cer GA2-ganglioside is a ganglioside that is found in the membranes of cells. GA2-Ganglioside has been shown to inhibit the growth of tumors by binding to macrophages and T cells, which are two types of white blood cells. It has also been shown that GA2-Ganglioside can be used as a target for an antibody response against human HL-60 tumor cells. The antibody response induces cell lysis and reduces the size of the tumor. GA2-Ganglioside has also been shown to have anti-inflammatory properties, which may be due to its ability to bind to ? subunits on bowel disease and infectious diseases, such as murine sarcoma virus, causing an antibody response that causes cell lysis and prevents replication of these viruses. Gangliotriosylceramide is a glycosphingolipid found in the central nervous system, peripheral nerves, and other tissues. It is composed of a ceramide molecule and three sugar residues, including galactose, N-acetylgalactosamine, and glucose. This molecule plays a crucial role in the regulation of neural signaling and communication within cells, and it is also involved in several cellular processes related to cell growth and differentiation. Physical and Chemical Properties Synthesis and Characterization Gangliotriosylceramide can be synthesized through several different methods, including chemical synthesis, enzymatic synthesis, and biosynthesis. Chemical synthesis involves the use of chemical reactions to create the molecule, while enzymatic synthesis uses specific enzymes to catalyze the formation of the molecule. Biosynthesis involves the use of cells to synthesize the molecule. The synthesized gangliotriosylceramide can be characterized using analytical methods such as high-performance liquid chromatography, electrospray ionization mass spectrometry, and nuclear magnetic resonance spectroscopy. These methods can identify the molecular weight, structure, purity, and other characteristics of the synthesized molecule. Analytical Methods Analytical methods such as mass spectrometry, chromatography, and nuclear magnetic resonance spectroscopy are commonly used to analyze gangliotriosylceramide. These methods allow researchers to determine the molecular weight, structure, and chemical composition of the molecule, as well as its stability and purity. Biological Properties Gangliotriosylceramide is involved in several biological processes, including cell growth, differentiation, apoptosis, and neural signaling. Research has shown that this molecule plays a role in neuronal migration, synaptic plasticity, and axonal and dendritic growth. It is also involved in the regulation of immune responses, including T cell activation and proliferation. Toxicity and Safety in Scientific Experiments Research has shown that gangliotriosylceramide is not toxic at low doses and can be safely used in scientific experiments. However, high doses of this molecule can result in toxicity and adverse effects, including liver damage, kidney damage, and immunological responses. Applications in Scientific Experiments Gangliotriosylceramide has several applications in scientific experiments, including the study of neural signaling, neurodegenerative diseases, and immune responses. Researchers have used this molecule to study neuronal cell migration, synaptic plasticity, and axonal and dendritic growth. It is also being studied as a potential therapeutic agent for diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Current State of Research Research on gangliotriosylceramide is ongoing, with new insights into its biological properties and potential therapeutic applications being discovered. Studies have shown that gangliotriosylceramide plays a crucial role in the regulation of neural signaling and communication within cells, and it is being investigated as a potential therapeutic agent for diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Potential Implications in Various Fields of Research and Industry Gangliotriosylceramide has potential implications in various fields of research and industry. In the pharmaceutical industry, it may be used as a therapeutic agent for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In the field of neuroscience, it may be used to study neuronal cell migration, synaptic plasticity, and axonal and dendritic growth. In addition, gangliotriosylceramide may have applications in the development of new vaccines and immunotherapies. Limitations and Future Directions The study of gangliotriosylceramide has several limitations, including the availability of the molecule and the complexity of its synthesis and characterization. Further research is needed to fully understand the biological properties and potential therapeutic applications of this molecule. Future research directions may include the development of new methods for the synthesis and characterization of gangliotriosylceramide, as well as the investigation of its potential uses in a wider range of diseases and disorders. Other potential directions may include the study of its interactions with other molecules and cellular pathways, as well as the development of new analytical methods for its analysis and detection. CAS Number 35960-33-9 Product Name Gangliotriosylceramide IUPAC Name N-[(E,2R,3S)-1-[5-[5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]octadecanamide Molecular Formula C56H104N2O18 Molecular Weight 1093(stearoyl) InChI InChI=1S/C56H104N2O18/c1-4-6-8-10-12-14-16-18-19-21-23-25-27-29-31-33-44(64)58-39(40(63)32-30-28-26-24-22-20-17-15-13-11-9-7-5-2)37-71-55-50(69)48(67)53(42(35-60)73-55)76-56-51(70)49(68)52(43(36-61)74-56)75-54-45(57-38(3)62)47(66)46(65)41(34-59)72-54/h30,32,39-43,45-56,59-61,63,65-70H,4-29,31,33-37H2,1-3H3,(H,57,62)(H,58,64)/b32-30+/t39-,40+,41?,42?,43?,45?,46?,47?,48?,49?,50?,51?,52?,53?,54?,55?,56?/m1/s1 SMILES CCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)OC3C(C(C(C(O3)CO)O)O)NC(=O)C)O)O)O)O)C(C=CCCCCCCCCCCCCC)O Synonyms Asialo-GM2; Gg3